These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 29541229)
21. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Zhu W; Shan X; Wang T; Shu Y; Liu P Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1. Ren A; Wen Z; Zheng L Exp Ther Med; 2019 Sep; 18(3):1653-1660. PubMed ID: 31410122 [TBL] [Abstract][Full Text] [Related]
23. miR-186-5p targeting SIX1 inhibits cisplatin resistance in non-small-cell lung cancer cells (NSCLCs). Liu X; Zhou X; Chen Y; Huang Y; He J; Luo H Neoplasma; 2020 Jan; 67(1):147-157. PubMed ID: 31686523 [TBL] [Abstract][Full Text] [Related]
24. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1. Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125a-5p targets LIM kinase 1 to inhibit cisplatin resistance of cervical cancer cells. Xu Y; Zheng Y; Duan Y; Ma L; Nan P Oncol Lett; 2021 May; 21(5):392. PubMed ID: 33777215 [TBL] [Abstract][Full Text] [Related]
26. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin. Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells. Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261 [TBL] [Abstract][Full Text] [Related]
28. Circ_0076305 regulates cisplatin resistance of non-small cell lung cancer via positively modulating STAT3 by sponging miR-296-5p. Dong Y; Xu T; Zhong S; Wang B; Zhang H; Wang X; Wang P; Li G; Yang S Life Sci; 2019 Dec; 239():116984. PubMed ID: 31647948 [TBL] [Abstract][Full Text] [Related]
30. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Zhu W; Zhu D; Lu S; Wang T; Wang J; Jiang B; Shu Y; Liu P Med Oncol; 2012 Mar; 29(1):384-91. PubMed ID: 21258880 [TBL] [Abstract][Full Text] [Related]
32. A Novel Long Non-coding RNA, MSTRG.51053.2 Regulates Cisplatin Resistance by Sponging the miR-432-5p in Non-small Cell Lung Cancer Cells. Zhang J; Xu C; Gao Y; Wang Y; Ding Z; Zhang Y; Shen W; Zheng Y; Wan Y Front Oncol; 2020; 10():215. PubMed ID: 32158694 [No Abstract] [Full Text] [Related]
33. LINC00665/miR-379-5p/GRP78 regulates cisplatin sensitivity in gastric cancer by modulating endoplasmic reticulum stress. Yue C; Yu C; Peng R; Wang J; Li G; Xu L Cytotechnology; 2021 Jun; 73(3):413-422. PubMed ID: 34149174 [TBL] [Abstract][Full Text] [Related]
34. Overexpression of miR-584-5p inhibits proliferation and induces apoptosis by targeting WW domain-containing E3 ubiquitin protein ligase 1 in gastric cancer. Li Q; Li Z; Wei S; Wang W; Chen Z; Zhang L; Chen L; Li B; Sun G; Xu J; Li Q; Wang L; Xu Z; Xia Y; Zhang D; Xu H; Xu Z J Exp Clin Cancer Res; 2017 Apr; 36(1):59. PubMed ID: 28431583 [TBL] [Abstract][Full Text] [Related]
35. miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD. Zhu M; Zhou X; Du Y; Huang Z; Zhu J; Xu J; Cheng G; Shu Y; Liu P; Zhu W; Wang T Mol Med Rep; 2016 Aug; 14(2):1742-50. PubMed ID: 27357419 [TBL] [Abstract][Full Text] [Related]
36. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway. Liu S; Wang Q; Liu Y; Xia ZY J Biosci; 2019 Sep; 44(4):. PubMed ID: 31502580 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells. Wang M; Zhang R; Zhang S; Xu R; Yang Q Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930 [TBL] [Abstract][Full Text] [Related]
38. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110 [TBL] [Abstract][Full Text] [Related]
39. MiR-219a-5p enhances cisplatin sensitivity of human non-small cell lung cancer by targeting FGF9. Rao C; Miao X; Zhao G; Zhang C; Shen H; Dong C; Yang M Biomed Pharmacother; 2019 Jun; 114():108662. PubMed ID: 30999114 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition. Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]